0.01Open0.01Pre Close1 Volume57 Open Interest20.00Strike Price1.00Turnover94.60%IV19.59%PremiumNov 22, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type-0.0115Delta0.0124Gamma2486.00Leverage Ratio-0.0070Theta0.0000Rho-28.70Eff Leverage0.0008Vega
Pfizer Stock Discussion
bottom or not?
more selling
Hugely Undervalued $2 Biotech With 21% Held Short $16 Price Target, Takeover Candidate, Soon Profitable. Fund that owns $Viking Therapeutics (VKTX.US)$ since 2022 below $10 a share is also investing in ESPR and expects the company will be a block buster.
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esper...
No comment yet